2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$8.65-$0.01 (-0.13%)
Price as of Nov 12, 2026 8:15 AM EST- $717.9MMarket Cap
- 132.80%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$8.65-$0.01 (-0.13%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.66 | ||
Change | +$0.31 (+3.71%) | ||
Open | $8.40 | ||
High | $8.72 | ||
Low | $8.30 | ||
Previous Close | $8.35 | ||
Volume | 1,070,704 | ||
30-Day Average Volume | 1,238,865 | ||
1-Week Change | 8.66% | ||
1-Month Change | -8.46% | ||
1-Year Change | 132.80% | ||
3-Year Change | 106.68% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 82.9M | ||
Total Assets | $239.1M | ||
Market Cap | $717.9M | ||
Enterprise Value | $492.4M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$11.5M | ||
Free Cash Flow | -$11.8M | ||
EBIT | -$11.5M | ||
EBITDA | -$11.4M | ||
Net Working Capital | $224.5M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -43 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 3 | ||
P/E | -48 | ||
PEG | N/A | ||
Price/Free Cash Flow | -61 | ||
Price/Operating Cash Flow | -61 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue